T cell factor 1 (Tcf1, encoded by Tcf7) is the top T-lineage transcription factor of a functionally defined hierarchy that drives commitment of thymocyte precursors to the T cell lineage; Notch signaling is the upstream inducer of Tcf1, which in turn activates Gata3 and Bcl11b. Garcia-Perez et al. (2020) showed that Tcf1-deficient double-negative 3 (DN3) thymocytes, though seemingly committed, express alternative-lineage master regulators, lose chromatin accessibility at T cell loci, and can dedifferentiate into non-T lineages; their Discussion and Fig. 6 legend leave several interlocking mechanistic questions open, which fall into five components. None of the five is fully closed in the literature to date: the formal in vivo test of dedifferentiation after post-commitment Tcf1 deletion has not been reported; the context-dependence of Tcf1's intrinsic HDAC versus β-catenin-dependent activator functions at commitment stages remains unsettled, although an intrinsically disordered N-terminal domain was shown in 2023 to control both activation of T cell genes and repression of a Gata2-driven alternative program; the causal chain from accessibility loss to alternative-lineage regulators is only partially delineated; Runx1/E2A positioning has been substantially reframed by network studies rather than resolved within the original linear hierarchy; and staged-deletion data show lymphoma follows germline or earliest-stage Tcf1 loss but not deletion from DN2–DN3 onward, leaving the lineage-infidelity-to-leukemogenesis causal question open in sharpened form.

Background

T lymphocytes develop in the thymus from bone-marrow-derived hematopoietic progenitors. The earliest thymocyte stages are called double-negative (DN) because they lack the CD4 and CD8 co-receptors; they progress DN1→DN2→DN3→DN4 before becoming double-positive (DP) cells. Irreversible commitment to the T lineage occurs around the DN3 stage, and is sealed by β-selection — the survival-and-proliferation checkpoint triggered when a successfully rearranged T cell receptor β chain pairs with the invariant pre-T cell receptor (pre-TCR). Notch signaling (a cell–cell signaling pathway in which the Notch1 receptor's intracellular domain translocates to the nucleus and, with the DNA-binding protein RBP-J, activates target genes) is required throughout this period; its first T-lineage-specific target gene is Tcf7, encoding the transcription factor Tcf1 (T cell factor 1), a high-mobility-group box DNA-binding protein. Tcf1 is classically viewed as the nuclear effector of canonical Wnt signaling because it binds β-catenin, but it also has β-catenin-independent functions and an N-terminal domain with intrinsic histone deacetylase (HDAC) activity — the enzymatic removal of acetyl groups from histones, generally associated with transcriptional repression. Its homolog Lef1 can partially compensate for it. Tcf1 directly activates the genes for Gata3 and Bcl11b, two transcription factors with a division of labor: Gata3 mainly suppresses myeloid and B cell fates, while Bcl11b activates the T cell-specific program. Retroviral rescue of Tcf1-deficient precursors with Bcl11b fully restores T cell development, establishing a functional epistasis hierarchy Notch→Tcf1→(Gata3, Bcl11b), which is the framework for this problem (Garcia-Perez et al. 2020). Two further strands frame the open questions. First, in B cell development the Pax5 transcription factor enforces commitment, and Pax5-deficient B cells demonstrably dedifferentiate in vivo into multipotent progenitors; Garcia-Perez et al. found an analogous but mechanistically distinct phenotype — Tcf1-deficient DN3 cells show promiscuous gene expression (including the alternative-lineage regulators Bcl11a, Pax5, and Pu.1), lose chromatin accessibility at T cell loci such as the Tcrb locus measured by ATAC-seq (assay for transposase-accessible chromatin with sequencing, a proxy for open chromatin), and, in vitro and upon transplantation, production of B and myeloid cells. Second, Tcf7−/− mice develop aggressive thymic T cell lymphomas, and in skin stem cells 'lineage infidelity' (expression of programs from other lineages) predisposes to malignancy — motivating the question whether Tcf1-loss-driven lineage infidelity is itself a leukemogenic force.

Problem Statement

The problem is the mechanistic completion, at molecular and in vivo causal level, of how Tcf1 enforces T-lineage commitment and fidelity and maintains the committed T cell state within the functionally defined Notch→Tcf1→(Gata3, Bcl11b) hierarchy. The five components below are all required. Each is resolved either by a documented mechanistic determination that answers that component as posed or, where no such determination exists, by a specific experiment whose predicted readouts would discriminate between the competing mechanistic explanations; prior work that does not answer the component as posed does not resolve it: (1) Dedifferentiation in vivo: determine whether committed thymocytes (DN3b or later — phenotypically defined DN3b cells are the candidate committed population) actually dedifferentiate to alternative lineages when Tcf1 is deleted after commitment, using conditional stage-specific Tcf7 deletion (a floxed allele — Tcf7 flanked by loxP sites — excised by a Cre recombinase under control of a late-acting promoter during thymocyte differentiation) combined with lineage tracing (heritable genetic marking of deleted cells and their descendants) or comparable in vivo readouts, so as to exclude developmental selection or surviving earlier progenitors as the explanation. (2) Dual activator/repressor activity: define the molecular basis of Tcf1's activator versus repressor functions at commitment stages — the respective roles and context-dependence of its intrinsic HDAC domain and of β-catenin-dependent activation in developing thymocytes, read against the partial compensation by Lef1 that makes Tcf1-deficient phenotypes incompletely penetrant. (3) Chromatin mechanism: delineate the causal chain linking Tcf1-dependent chromatin accessibility at T cell loci to the activation of alternative-lineage master regulators. (4) Hierarchy extension: establish whether Runx1 (runt-related transcription factor 1) and E2A (the Tcf3-encoded member of the E-protein basic helix-loop-helix transcription factor family) play unique, redundant, or synergistic roles relative to Tcf1, Gata3, and Bcl11b during specification and commitment — roles not shown in the Notch→Tcf1→(Gata3, Bcl11b) hierarchy. (5) Leukemogenesis: determine whether the lineage infidelity caused by Tcf1 loss is itself a previously unrecognized factor in leukemogenesis — loss of Tcf1 leads to rapid development of T cell lymphomas, and lineage infidelity may also serve as a previously unrecognized factor in leukemogenesis — and, if so, by what mechanism.

References

  1. Garcia-Perez L, Famili F, Cordes M, Brugman M, van Eggermond M, Wu H, Chouaref J, Granado DSL, Tiemessen MM, Pike-Overzet K, Daxinger L, Staal FJT. Functional definition of a transcription factor hierarchy regulating T cell lineage commitment. Science Advances 6(31):eaaw7313 (2020). doi:10.1126/sciadv.aaw7313, https://doi.org/10.1126/sciadv.aaw7313 (PMC7400773)
  2. Wang F, Qi Z, Yao Y, Yu G, Feng T, Zhao T, Xue HH, Zhao Y, Jiang P, Bao L, Yu S. Exploring the stage-specific roles of Tcf-1 in T cell development and malignancy at single-cell resolution. Cellular & Molecular Immunology (2021). doi:10.1038/s41423-020-00527-1, https://doi.org/10.1038/s41423-020-00527-1 (PMID 32868912)
  3. Goldman N, Chandra A, Johnson I, Sullivan MA, Patil AR, Vanderbeck A, Jay A, Zhou Y, Ferrari EK, Mayne L, Aguilan J, Xue HH, Faryabi RB, Wherry EJ, Sidli S, Maillard I, Vahedi G. Intrinsically disordered domain of transcription factor TCF-1 is required for T cell developmental fidelity. Nature Immunology (2023). doi:10.1038/s41590-023-01599-7, https://doi.org/10.1038/s41590-023-01599-7 (PMID 37592014)
  4. Zhao X, Hu SS, Lee WH, Zakrzewski JL, Mi QS, Rosenstein RK, Zang C, Ma X, Xue HH. Single-cell multiomics identifies Tcf1 and Lef1 as key initiators of early thymic progenitor fate. Science Immunology (2025). doi:10.1126/sciimmunol.adq8970, https://doi.org/10.1126/sciimmunol.adq8970 (PMID 40938954)
  5. Shin B, Zhou W, Wang J, Gao F, Rothenberg EV. Runx factors launch T cell and innate lymphoid programs via direct and gene network-based mechanisms. Nature Immunology (2023). doi:10.1038/s41590-023-01585-z, https://doi.org/10.1038/s41590-023-01585-z (PMID 37563311)
  6. Kama Y, Hirano KI, Masuhara K, Endo Y, Suzuki Y, Fujimoto M, Matsuda T, Yahata T, Kato M, Hozumi K, Tanaka T, Hosokawa H. Notch interaction with RUNX factors regulates initiation of the T-lineage program. Journal of Experimental Medicine (2026). doi:10.1084/jem.20250911, https://doi.org/10.1084/jem.20250911 (PMID 41342880)
  7. Miyazaki K, Horie K, Watanabe H, Hidaka R, Hayashi R, Hayatsu N, Fujiwara K, Kuwata R, Uehata T, Ochi Y, Takenaka M, Kawaguchi RK, Ikuta K, Takeuchi O, Ogawa S, Hozumi K, Holländer GA, Kondoh G, Akiyama T, Miyazaki M. A feedback amplifier circuit with Notch and E2A orchestrates T-cell fate and suppresses the innate lymphoid cell lineages during thymic ontogeny. Genes & Development (2025). doi:10.1101/gad.352111.124, https://doi.org/10.1101/gad.352111.124 (PMID 39904558)
  8. Verma A, Aylward B, Ma F, Sherman CA, Chopp L, Shinton S, Roy R, Fahl S, Contreras A, Koenitzer B, Awasthi P, Mazan-Mamczarz K, De S, Ollikainen N, Qiu X, Bosselut R, Sen R, Wiest DL, Sen JM. TCF1 dosage determines cell fate during T cell development. Science Advances (2024). doi:10.1126/sciadv.ado5982, https://doi.org/10.1126/sciadv.ado5982 (PMID 39602533)
  9. Duke-Cohan JS, Akitsu A, Mallis RJ, Messier CM, Lizotte PH, Aster JC, Hwang W, Lang MJ, Reinherz EL. Pre-T cell receptor self-MHC sampling restricts thymocyte dedifferentiation. Nature (2023). doi:10.1038/s41586-022-05555-7, https://doi.org/10.1038/s41586-022-05555-7 (PMID 36410718)
  10. Gounari F, Khazaie K. TCF-1: a maverick in T cell development and function. Nature Immunology 23(5):671-678 (2022). doi:10.1038/s41590-022-01194-2, https://doi.org/10.1038/s41590-022-01194-2 (PMID 35487986)
  11. Shin B, Rothenberg EV. Multi-modular structure of the gene regulatory network for specification and commitment of murine T cells. Frontiers in Immunology (2023). doi:10.3389/fimmu.2023.1108368, https://doi.org/10.3389/fimmu.2023.1108368 (PMID 36817475)
  12. Shin B, Chang SJ, MacNabb BW, Rothenberg EV. Transcriptional network dynamics in early T cell development. Journal of Experimental Medicine (2024). doi:10.1084/jem.20230893, https://doi.org/10.1084/jem.20230893 (PMID 39167073)
  13. Antoszewski M, Fournier N, Ruiz Buendía G, Lourenco J, Liu Y, Sugrue T, Dubey C, Nkosi M, Pritchard CEJ, Huijbers IJ, Segat GC, Alonso-Moreno S, Serracanta E, Belver L, Ferrando AA, Ciriello G, Weng AP, Koch U, Radtke F. Tcf1 is essential for initiation of oncogenic Notch1-driven chromatin topology in T-ALL. Blood 139(16):2483-2498 (2022). doi:10.1182/blood.2021012077, https://doi.org/10.1182/blood.2021012077 (PMID 35020836)
  14. Arnovitz S, Mathur P, Tracy M, Mohsin A, Mondal S, Quandt J, Hernandez KM, Khazaie K, Dose M, Emmanuel AO, Gounari F. Tcf-1 promotes genomic instability and T cell transformation in response to aberrant β-catenin activation. Proceedings of the National Academy of Sciences USA (2022). doi:10.1073/pnas.2201493119, https://doi.org/10.1073/pnas.2201493119 (PMID 35921443)
  15. Gutierrez A, Kentsis A. Co-option of lineage plasticity as a hallmark of multipotent acute leukemias. Blood Neoplasia 3(3):100231 (2026). doi:10.1016/j.bneo.2026.100231, https://doi.org/10.1016/j.bneo.2026.100231 (PMID 42255260)
  16. McCullen M, Oltz E. The multifaceted roles of TCF1 in innate and adaptive lymphocytes. Advances in Immunology (2024). doi:10.1016/bs.ai.2024.10.001, https://doi.org/10.1016/bs.ai.2024.10.001 (PMID 39523028)